Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05506046 · ClinicalTrials.gov registry record · NA
Messages About Reduced Nicotine in Combusted Tobacco Products
A NA study, sponsored by Georgia State University.
- Completed
- Registry status
- NA
- Development phase
- 1,901
- Enrollment target
NCT05506046 is a NA study that has completed, run by Georgia State University. The registered enrollment target is 1,901 participants.
The verdict
NCT05506046, a NA study, has completed, sponsored by Georgia State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,901 participants
- Enrollment target
Study Summary
The investigators will conduct a message-exposure experiment with nationally representative samples of smokers, dual-users (cigarettes and e-cigarettes), and young adult non-smokers (aged 18-29). Experimental messages will address the reduction of nicotine in cigarettes. Participants will also complete a follow-up survey after 2 weeks, measuring their recall of the messages and behaviors since message exposure.
Interventions
- BEHAVIORAL Reduced nicotine message exposure
- BEHAVIORAL Modified risk message exposure
- BEHAVIORAL Combined message exposure (reduced nicotine + modified risk)
- BEHAVIORAL Control message exposure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,901 participants |
| Start Date | 2022-10-12 |
| Est. Completion | 2023-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05506046
The ClinicalTrials.gov registry entry for NCT05506046 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,901 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgia State University, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Reduced nicotine message exposure is the first listed.
NCT05506046 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05506046 about?
NCT05506046 is a clinical study titled "Messages About Reduced Nicotine in Combusted Tobacco Products". The investigators will conduct a message-exposure experiment with nationally representative samples of smokers, dual-users (cigarettes and e-cigarettes), and young adult non-smokers (aged 18-29). Experimental messages will address the reduction of nicotine in cigarettes. Participants will also comp...
What is the current status of trial NCT05506046?
This trial is currently completed. It is a NA study. The enrollment target is 1,901 participants. The study started on 2022-10-12. Estimated completion is 2023-02-28.
What interventions are being tested in trial NCT05506046?
The interventions under investigation include: Reduced nicotine message exposure (BEHAVIORAL), Modified risk message exposure (BEHAVIORAL), Combined message exposure (reduced nicotine + modified risk) (BEHAVIORAL), Control message exposure (BEHAVIORAL).
Who is sponsoring clinical trial NCT05506046?
This trial is sponsored by Georgia State University, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.